These fluctuations complicate the management of anaemia as the Hb levels are difficult to maintain within a targeted range, leading to suboptimal treatment responses and increased cardiovascular risks, which significantly affect patient well-being [13]. Here, GSTM1 is linked to anemia (phenotype).